The table below shows Cue Biopharma, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$27.47M
$9.29M
$5.49M
$1.25M
$14.94M
$3.15M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$37.74M
$36.30M
$40.80M
$38.58M
$41.35M
$33.55M
SG&A
$16.24M
CUE annual revenue (10-K history)
Cue Biopharma, Inc. reported annual revenue of $27.47M for fiscal year 2025. That is up 195.7% from $9.29M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $1.14M (FY 2018) to $27.47M. Figures come from the company's audited annual reports as filed with the SEC.